Description
Global CBD Market Analysis
Cannabidiol Market Forecast till 2030
Market Overview
Cannabis plants contain cannabidiol (CBD), a non-addictive substance. The compound is found in cannabis in greater concentrations than tetrahydrocannabinol (THC). This industry consists of a variety of forms (solids, liquids) routes of administration (tinctures, capsules, inhalation (smoke or vapour), aerosol sprays) and products (food grade, therapeutic grade).
Cannabidiol, which does not produce psychoactive effects, is the most widely consumed of the cannabinoids. It has been found to be effective in treating a variety of conditions, including anxiety, depression, stress, diabetes, pain, cancer symptoms, and inflammation. This has led to an increase in demand for CBD oil, resulting in a large growth in the global market. This has prompted commercial retailers to invest more in CBD oil, as it offers high profit margins. Wellness and health retailers, such as CVS Health, Rite Aid, and Walgreens Boots Alliance have begun to offer products containing CBD oil.
Segment Overview
The global market has been segregated into form, product, route of administration, application, end user and regional segments. The global CBD market has been divided into Solid and Liquid. Considering on routes of administration, the global market of cannabidiol is divided into Tincture, Capsules, Inhalation, Aerosol Spray. According to the Product type the global market has been divided into Therapeutic Grade and Food Grade. Based on application, the global cannabidiol market is sub-segmented into Fibromyalgia, Diabetes, Protein Bars, Neurogenerative Disorder, Energy Drinks. The End User segment covers Food & Beverage and Healthcare, while Source segment includes Organic and Inorganic.
Regional Analysis
The worldwide Cannabidiol market has been concentrated across North America, Europe, Asia Pacific, and Rest of the World. Americas represented the biggest market portion in 2021. According to the WHO, about 147 million people around the world use marijuana and other cannabis-related products. Furthermore, 22.2 million Americans who use cannabis-based products are 12 years old or older. Europe has the second largest position of regional market in the cannabidiol. The use of CBD is legal on the European market. The Ministry of Agriculture, the Bulgarian Food Safety Agency and the Ministry of Agriculture have all approved the use of cannabidiol in Europe. These agencies have issued ‘free certificates of sale’ for CBD products. These legalizations and approvals are driving the European market’s growth. In Europe, the practice is legal, but there are some positive restrictions as well. Also, cannabis laws are different in various European countries. Various companies participating in the market are creating various opportunities and scope for development.
Major Players
Folium Biosciences, Aphria Inc., Elixinol Global Limited, LLC., Green Roads of Florida, Freedom Leaf Inc, CBD Health Solutions, CV Sciences, Isodiol International Inc, Canopy Growth Corporation and Medical Marijuana Inc. are among the leading companies operating in the global Cannabidiol (CBD) Market.
COVID 19 Impacts
The spread of the covid-19 virus has caused extraordinary lockdowns in industries around the world, disrupting and destroying many of their daily operations. This has caused retail stores to close, leading to a shortfall in the global market’s supply chain. The primary source of this disruption has been the shutdown of raw material-producing countries such as China and India. Moreover, the supply chain and production of cannabidiol-based products in the US has been severely impacted by the disruption of other raw material supplies.
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 MARKET STRUCTURE 18
3 RESEARCH METHODOLOGY
3.1 RESEARCH METHODOLOGY 19
3.2 PRIMARY RESEARCH 20
3.3 SECONDARY RESEARCH 21
3.4 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.5 FORECAST MODEL 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVERS 24
4.2.1 GROWING RESEARCH AND DEVELOPMENT ACTIVITIES AND FINANCIAL SUPPORT BY VARIOUS PRIVATE AND
GOVERNMENT ORGANIZATIONS FOR CANNABINOID RESEARCH 24
4.2.2 RISING OCCURRENCE OF CHRONIC DISEASES AND RELATED COMPLICATIONS 24
4.2.3 LEGALIZATION OF CANNABINOID (CBD) IN VARIOUS REGIONS 24
4.3 RESTRAINTS 25
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS 25
4.3.2 STRINGENT GOVERNMENT POLICIES 25
4.4 OPPORTUNITIES 25
4.4.1 IMPROVING STATUS OF CANNABIS IN ASIAN COUNTRIES 25
4.5 MEGATRENDS AND TECHNOLOGICAL ADVANCEMENTS 26
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 27
5.1.1 RESEARCH & DEVELOPMENT 27
5.1.2 MANUFACTURING 27
5.1.3 DISTRIBUTION AND SALES 28
5.1.4 POST-SALES MONITORING 28
5.2 PORTER’S FIVE FORCES MODEL 29
5.2.1 THREAT OF NEW ENTRANTS 29
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 BARGAINING POWER OF BUYERS 30
5.2.4 THREAT OF SUBSTITUTES 30
5.2.5 INTENSITY OF RIVALRY 30
5.3 ETOP ANALYSIS 31
5.3.1 THREAT 31
5.3.1.1 STRINGENT REGULATORY SCENARIO 31
5.3.2 OPPORTUNITIES 31
5.3.2.1 EXPLORING NEW APPLICATIONS 31
5.4 INVESTMENT OPPORTUNITY ANALYSIS 31
5.5 PRICING ANALYSIS 32
5.6 REGULATORY SCENARIO 32
6 CBD MARKET, BY FORM
6.1 INTRODUCTION 33
6.2 SOLID 34
6.3 LIQUID 34
7 CBD MARKET, BY ROUTES OF ADMINISTRATION
7.1 INTRODUCTION 35
7.2 TINCTURE 36
7.3 CAPSULES 36
7.4 INHALATION (SMOKE OR VAPOR) 37
7.5 AEROSOL SPRAY 37
8 CBD MARKET, BY PRODUCT
8.1 INTRODUCTION 38
8.2 FOOD GRADE 39
8.3 THERAPEUTIC GRADE 39
9 CBD MARKET, BY APPLICATION
9.1 INTRODUCTION 40
9.2 NEUROGENERATIVE DISORDER 41
9.3 FIBROMYALGIA 41
9.4 DIABETES 42
9.5 PROTEIN BARS 42
9.6 ENERGY DRINKS 42
10 CBD MARKET, BY END USE
10.1 INTRODUCTION 43
10.2 FOOD & BEVERAGE 44
10.3 HEALTHCARE 44
11 CBD MARKET, BY SOURCE
11.1 INTRODUCTION 45
11.2 ORGANIC 46
11.3 INORGANIC 46
12 GLOBAL CBD MARKET, BY REGION
12.1 INTRODUCTION 47
12.2 AMERICAS 49
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1 NORTH AMERICA 51
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.1 US 53
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.2 CANADA 55
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2 LATIN AMERICA 57
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.1 BRAZIL 59
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.2 REST OF LATIN AMERICA 61
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3 EUROPE 64
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1 WESTERN EUROPE 66
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.1 FRANCE 68
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.2 ITALY 70
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.3 GERMANY 72
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.4 UK 74
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.5 REST OF WESTERN EUROPE 76
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.2 EASTERN EUROPE 78
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4 ASIA-PACIFIC 81
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.1 JAPAN 83
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.2 CHINA 85
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.3 INDIA 87
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.4 REST OF ASIA-PACIFIC 89
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.5 MIDDLE EAST & AFRICA 91
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
13 COMPETITIVE LANDSCAPE
13.1 COMPETITIVE LANDSCAPE 94
14 COMPANY PROFILES
14.1 APHRIA INC. 97
14.1.1 COMPANY OVERVIEW 97
14.1.2 FINANCIAL OVERVIEW 97
14.1.3 PRODUCTS/SERVICES OFFERED 98
14.1.4 KEY DEVELOPMENTS 98
14.1.5 SWOT ANALYSIS 98
14.1.6 KEY STRATEGIES 99
14.2 FOLIUM BIOSCIENCES 100
14.2.1 COMPANY OVERVIEW 100
14.2.2 FINANCIAL OVERVIEW 100
14.2.3 PRODUCTS/SERVICES OFFERED 101
14.2.4 KEY DEVELOPMENTS 101
14.2.5 SWOT ANALYSIS 102
14.2.6 KEY STRATEGIES 102
14.3 FREEDOM LEAF, INC. 103
14.3.1 COMPANY OVERVIEW 103
14.3.2 FINANCIAL OVERVIEW 103
14.3.3 PRODUCTS/SERVICES OFFERED 103
14.3.4 KEY DEVELOPMENTS 104
14.3.5 SWOT ANALYSIS 104
14.3.6 KEY STRATEGIES 104
14.4 GREEN ROADS OF FLORIDA, LLC 105
14.4.1 COMPANY OVERVIEW 105
14.4.2 FINANCIAL OVERVIEW 105
14.4.3 PRODUCTS/SERVICES OFFERED 105
14.4.4 KEY DEVELOPMENTS 105
14.4.5 SWOT ANALYSIS 106
14.4.6 KEY STRATEGIES 106
14.5 CBD HEALTH SOLUTIONS, LLC 107
14.5.1 COMPANY OVERVIEW 107
14.5.2 FINANCIAL OVERVIEW 107
14.5.3 PRODUCTS/SERVICES OFFERED 107
14.5.4 KEY DEVELOPMENTS 107
14.5.5 SWOT ANALYSIS 108
14.5.6 KEY STRATEGIES 108
14.6 ENDOCA 109
14.6.1 COMPANY OVERVIEW 109
14.6.2 FINANCIAL OVERVIEW 109
14.6.3 PRODUCTS/SERVICES OFFERED 110
14.6.4 KEY DEVELOPMENTS 110
14.6.5 SWOT ANALYSIS 111
14.6.6 KEY STRATEGIES 111
14.7 ISODIOL INTERNATIONAL INC. 112
14.7.1 COMPANY OVERVIEW 112
14.7.2 FINANCIAL OVERVIEW 112
14.7.3 PRODUCTS/SERVICES OFFERED 112
14.7.4 KEY DEVELOPMENTS 113
14.7.5 SWOT ANALYSIS 113
14.7.6 KEY STRATEGIES 113
14.8 CV SCIENCES, INC. 114
14.8.1 COMPANY OVERVIEW 114
14.8.2 FINANCIAL OVERVIEW 114
14.8.3 PRODUCTS/SERVICES OFFERED 114
14.8.4 KEY DEVELOPMENTS 115
14.8.5 SWOT ANALYSIS 115
14.8.6 KEY STRATEGIES 115
14.9 MEDICAL MARIJUANA, INC. 116
14.9.1 COMPANY OVERVIEW 116
14.9.2 FINANCIAL OVERVIEW 116
14.9.3 PRODUCTS/SERVICES OFFERED 117
14.9.4 KEY DEVELOPMENTS 117
14.9.5 SWOT ANALYSIS 118
14.9.6 KEY STRATEGIES 118
14.10 CANOPY GROWTH CORPORATION 119
14.10.1 COMPANY OVERVIEW 119
14.10.2 FINANCIAL OVERVIEW 119
14.10.3 PRODUCTS/SERVICES OFFERED 119
14.10.4 KEY DEVELOPMENTS 120
14.10.5 SWOT ANALYSIS 120
14.10.6 KEY STRATEGIES 120
14.11 ELIXINOL GLOBAL LIMITED 121
14.11.1 COMPANY OVERVIEW 121
14.11.2 FINANCIAL OVERVIEW 121
14.11.3 PRODUCTS/SERVICES OFFERED 122
14.11.4 KEY DEVELOPMENTS 122
14.11.5 SWOT ANALYSIS 122
14.11.6 KEY STRATEGIES 122
15 APPENDIX
15.1 REFERENCES 123
15.2 RELATED REPORTS 123
Reviews
There are no reviews yet.